ΠΠ½Π°Π»ΠΈΠ· ΠΌΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠ² ΠΏΠ΅ΠΏΡΠΈΠ΄Π½ΡΡ ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠΎΠ² Π΄Π»Ρ ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈ Π΄Π΅ΡΠ΅ΡΠΌΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠ° Π±Π΅Π»ΠΊΠΎΠ²
ΠΠ΅Π΄ΠΎΡΡΠ°ΡΠΊΠΈ ΡΠΊΠ°Π·Π°Π½Π½ΡΡ Π²ΡΡΠ΅ ΠΏΠΎΠ΄Ρ ΠΎΠ΄ΠΎΠ² Ρ ΠΎΡΠΎΡΠΎ ΠΈΠ·Π²Π΅ΡΡΠ½Ρ. Π Π±Π°Π·Π°Ρ Π΄Π°Π½Π½ΡΡ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡΡΠ΅ΠΌΡΡ ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠΎΠ² ΡΠΎΠ΄Π΅ΡΠΆΠΈΡΡΡ ΠΈΠ·Π±ΡΡΠΎΡΠ½Π°Ρ ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΡ, Π²ΠΊΠ»ΡΡΠ°Ρ ΠΎΡΠΈΠ±ΠΊΠΈ ΡΠ΅ΠΊΠ²Π΅Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ, ΡΡΠΎ ΡΡΠ»ΠΎΠΆΠ½ΡΠ΅Ρ Π°Π½Π°Π»ΠΈΠ· ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² ΠΌΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ. ΠΠ½Π°Π»ΠΈΠ·ΠΈΡΡΡ ΠΎΠ±ΡΠ°Π·Π΅Ρ, Π² ΠΊΠΎΡΠΎΡΠΎΠΌ ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½ΠΎ Π½Π΅ΡΠΊΠΎΠ»ΡΠΊΠΎ ΡΠΎΡΠ΅Π½ Π±Π΅Π»ΠΊΠΎΠ², ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ ΠΌΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΡ Π½Π΅ΠΎΠ±Ρ ΠΎΠ΄ΠΈΠΌΠΎ ΡΠΎΠΏΠΎΡΡΠ°Π²Π»ΡΡΡ Ρ Π½Π°ΠΊΠΎΠΏΠ»Π΅Π½Π½ΡΠΌΠΈ Π·Π° Π΄Π΅ΡΡΡΠΊΠΈ Π»Π΅Ρ ΡΠΎΡΠ½ΡΠΌΠΈ ΡΡΡΡΡ… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
- Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- ΠΡΠ΄Π΅ΡΠΆΠΊΠ°
- ΠΠΈΡΠ΅ΡΠ°ΡΡΡΠ°
- ΠΡΡΠ³ΠΈΠ΅ ΡΠ°Π±ΠΎΡΡ
- ΠΠΎΠΌΠΎΡΡ Π² Π½Π°ΠΏΠΈΡΠ°Π½ΠΈΠΈ
Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- ΠΠΠΠΠΠΠΠ, Π¦ΠΠΠ¬ Π ΠΠΠΠΠ§Π
- 2. ΠΠΠΠΠ ΠΠΠ’ΠΠ ΠΠ’Π£Π Π«
- 2. 1. ΠΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΡ Π² ΠΏΡΠΎΡΠ΅ΠΎΠΌΠΈΠΊΠ΅
- 2. 1. 1. ΠΠ±ΡΠΈΠ΅ ΠΏΡΠΈΠ½ΡΠΈΠΏΡ
- 2. 1. 2. ΠΡΠΎΡΠ΅ΠΎΠΌΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΌΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΠΈ
- 2. 1. 3. ΠΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ Π±Π΅Π»ΠΊΠΎΠ² ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΎΡΠΏΠ΅ΡΠ°ΡΠΊΠΎΠ² ΠΏΠ΅ΠΏΡΠΈΠ΄Π½ΡΡ ΠΌΠ°ΡΡ
- 2. 1. 4. ΠΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ Π±Π΅Π»ΠΊΠΎΠ² ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΎΡΠΏΠ΅ΡΠ°ΡΠΊΠΎΠ² ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠ°ΡΠΈΠΈ ΠΏΠ΅ΠΏΡΠΈΠ΄ΠΎΠ²
- 2. 2. ΠΠ½ΡΠ΅ΡΠΏΡΠ΅ΡΠ°ΡΠΈΡ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² ΠΌΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ Π±Π΅Π»ΠΊΠΎΠ²
- 2. 2. 1. ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΡΠΏΠΈΡΠΊΠ° ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ Π±Π΅Π»ΠΊΠΎΠ²
- 2. 2. 2. ΠΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ Π²ΡΡΠΎΠΊΠΎΠ³ΠΎΠΌΠΎΠ»ΠΎΠ³ΠΈΡΠ½ΡΡ Π±Π΅Π»ΠΊΠΎΠ²
- 2. 2. 3. ΠΠ°Π·Ρ Π΄Π°Π½Π½ΡΡ Π°ΠΌΠΈΠ½ΠΎΠΊΠΈΡΠ»ΠΎΡΠ½ΡΡ ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎΡΡΠ΅ΠΉ Π±Π΅Π»ΠΊΠΎΠ²
- 2. 3. ΠΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΏΡΠΎΠ΄ΡΠΊΡΠΎΠ² ΠΎΠ΄Π½ΠΎΠ³ΠΎ Π³Π΅Π½Π°
- 2. 3. 1. ΠΡΠΎΡΠ΅ΠΎΡΠΈΠΏΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΠΈ ΠΏΠΎΠΏΡΠ»ΡΡΠΈΠΎΠ½Π½Π°Ρ ΠΏΡΠΎΡΠ΅ΠΎΠΌΠΈΠΊΠ°
- 2. 3. 2. ΠΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ ΠΌΠΈΠΊΡΠΎΠ³Π΅ΡΠ΅ΡΠΎΠ³Π΅Π½Π½ΠΎΡΡΠΈ Π±Π΅Π»ΠΊΠΎΠ² ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ «ΡΠ²Π΅ΡΡ Ρ-Π²Π½ΠΈΠ·»
- 2. 3. 3. ΠΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈ-Π΄Π΅ΡΠ΅ΡΠΌΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠ° Π±Π΅Π»ΠΊΠΎΠ² ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ «ΡΠ½ΠΈΠ·Ρ-Π²Π²Π΅ΡΡ »
- 2. 3. 4. ΠΠ°Π·Ρ Π΄Π°Π½Π½ΡΡ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠΎΠ² Π±Π΅Π»ΠΊΠΎΠ² ΠΈ Π³Π΅Π½ΠΎΠ²
- 2. 3. 5. Π Π΅ΠΏΠΎΠ·ΠΈΡΠΎΡΠΈΠΈ ΠΌΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΡ Π΄Π°Π½Π½ΡΡ
- 2. 1. ΠΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΡ Π² ΠΏΡΠΎΡΠ΅ΠΎΠΌΠΈΠΊΠ΅
- 3. 1. ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ
- 3. 1. 1. ΠΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π΄Π°Π½Π½ΡΠ΅ Π΄Π»Ρ Π±Π΅Π»ΠΊΠΎΠ² ΠΌΠΈΠΊΡΠΎΡΠΎΠΌΠ°Π»ΡΠ½ΠΎΠΉ ΡΡΠ°ΠΊΡΠΈΠΈ ΠΏΠ΅ΡΠ΅Π½ΠΈ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°
- 3. 1. 2. ΠΠΎΠ½ΡΡΠΎΠ»ΡΠ½ΡΠΉ Π½Π°Π±ΠΎΡ ΠΌΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠ² «Aurum Dataset»
- 3. 1. 3. ΠΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π΄Π°Π½Π½ΡΠ΅ ΠΏΡΠΎΡΠ΅ΠΎΠΌΠ½ΠΎΠ³ΠΎ ΡΠ΅ΠΏΠΎΠ·ΠΈΡΠΎΡΠΈΡ PRIDE
- 3. 1. 4. ΠΠ°Π·Ρ Π΄Π°Π½Π½ΡΡ Π°ΠΌΠΈΠ½ΠΎΠΊΠΈΡΠ»ΠΎΡΠ½ΡΡ ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎΡΡΠ΅ΠΉ Π±Π΅Π»ΠΊΠΎΠ² ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°
- 3. 1. 5. ΠΠ°Π½Π½ΡΠ΅ ΠΎ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΡΡ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠ°Ρ Π±Π΅Π»ΠΊΠΎΠ² ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°
- 3. 2. ΠΠ΅ΡΠΎΠ΄Ρ
- 3. 2. 1. ΠΠ΅Π±-ΡΠ΅ΡΠ²Π΅Ρ ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ Π±Π΅Π»ΠΊΠΎΠ² ΠΏΠΎ ΠΌΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠ°ΠΌ
- 3. 2. 2. ΠΠ°ΠΊΠ΅ΡΠ½Π°Ρ ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΠ° ΠΌΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠ² ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΎΡΠΏΠ΅ΡΠ°ΡΠΊΠΎΠ² ΠΏΠ΅ΠΏΡΠΈΠ΄Π½ΡΡ ΠΌΠ°ΡΡ
- 3. 2. 3. ΠΠ°ΠΊΠ΅ΡΠ½Π°Ρ ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΠ° ΡΠ°Π½Π΄Π΅ΠΌΠ½ΡΡ ΠΌΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠ²
- 3. 2. 4. ΠΠ΄Π½ΠΎΠΌΠ΅ΡΠ½ΠΎΠ΅ ΠΏΡΠΎΡΠ΅ΠΎΠΌΠ½ΠΎΠ΅ ΠΊΠ°ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅
- 3. 2. 5. ΠΡΠΎΠ³ΡΠ°ΠΌΠΌΠ½Π°Ρ ΡΠ΅Π°Π»ΠΈΠ·Π°ΡΠΈΡ ΠΈΡΠ΅ΡΠ°ΡΠΈΠ²Π½ΠΎΠ³ΠΎ Π°Π»Π³ΠΎΡΠΈΡΠΌΠ° ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ ΠΠΠ
- 3. 2. 6. ΠΠ°Π»ΠΈΠ΄Π°ΡΠΈΡ Π°Π»Π³ΠΎΡΠΈΡΠΌΠ° ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ ΠΠΠ
- 4. 1. Π£Π²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠ΅ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ ΠΏΠΎΠΊΡΡΡΠΈΡ Π°ΠΌΠΈΠ½ΠΎΠΊΠΈΡΠ»ΠΎΡΠ½ΡΡ
ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎΡΡΠ΅ΠΉ ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΡΠΌΠΈ ΠΏΠ΅ΠΏΡΠΈΠ΄Π°ΠΌΠΈ
- 4. 1. 1. ΠΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ Π±Π΅Π»ΠΊΠΎΠ² Π² ΡΡΠ΅Π·Π°Ρ Π³Π΅Π»Ρ
- 4. 1. 2. ΠΠ΄Π½ΠΎΠΌΠ΅ΡΠ½ΡΠ΅ ΠΏΡΠΎΡΠ΅ΠΎΠΌΠ½ΡΠ΅ ΠΊΠ°ΡΡΡ ΠΈ ΠΈΡ ΡΠ²ΠΎΠΉΡΡΠ²Π°
- 4. 1. 3. ΠΡΡΠ²Π»Π΅Π½ΠΈΠ΅ Π²ΡΡΠΎΠΊΠΎΠ³ΠΎΠΌΠΎΠ»ΠΎΠ³ΠΈΡΠ½ΡΡ Π±Π΅Π»ΠΊΠΎΠ² Π½Π°Π΄ΡΠ΅ΠΌΠ΅ΠΉΡΡΠ²Π° ΡΠΈΡΠΎΡ ΡΠΎΠΌΠΎΠ² Π 450 Π·Π° ΡΡΠ΅Ρ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΡ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ ΠΏΠΎΠΊΡΡΡΠΈΡ Π°ΠΌΠΈΠ½ΠΎΠΊΠΈΡΠ»ΠΎΡΠ½ΡΡ ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎΡΡΠ΅ΠΉ ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΡΠΌΠΈ ΠΏΠ΅ΠΏΡΠΈΠ΄Π°ΠΌΠΈ
- 4. 2. ΠΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ ΠΠΠ Π² Π±Π΅Π»ΠΊΠ°Ρ Π½Π°Π΄ΡΠ΅ΠΌΠ΅ΠΉΡΡΠ²Π° ΡΠΈΡΠΎΡ ΡΠΎΠΌΠΎΠ² Π
- 4. 3. ΠΠ»Π³ΠΎΡΠΈΡΠΌ ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ ΠΠΠ
- 4. 3. 1. ΠΡΠ΅ΡΠ°ΡΠΈΠ²Π½Π°Ρ ΡΡ Π΅ΠΌΠ° ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΠΈ ΡΠ°Π½Π΄Π΅ΠΌΠ½ΡΡ ΠΌΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠ²
- 4. 3. 2. Π§ΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ ΠΈ ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ½ΠΎΡΡΡ Π°Π»Π³ΠΎΡΠΈΡΠΌΠ° ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ ΠΠΠ
- 4. 4. ΠΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΈΡΠ΅ΡΠ°ΡΠΈΠ²Π½ΠΎΠ³ΠΎ Π°Π»Π³ΠΎΡΠΈΡΠΌΠ° Π΄Π»Ρ Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ ΠΠΠ Π² ΠΌΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΡ
Π΄Π°Π½Π½ΡΡ
ΠΏΡΠΎΡΠ΅ΠΎΠΌΠ½ΠΎΠ³ΠΎ ΡΠ΅ΠΏΠΎΠ·ΠΈΡΠΎΡΠΈΡ PRIDE
- 4. 4. 1. ΠΡΡ ΠΎΠ΄Π½ΡΠ΅ Π΄Π°Π½Π½ΡΠ΅, ΠΈΡΠΏΠΎΠ»ΡΠ·ΡΠ΅ΠΌΡΠ΅ Π΄Π»Ρ Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ ΠΠΠ
- 4. 4. 2. ΠΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ ΠΏΠ΅ΠΏΡΠΈΠ΄ΠΎΠ² ΠΈ Π±Π΅Π»ΠΊΠΎΠ² Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΌΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΡ Π΄Π°Π½Π½ΡΡ , Π·Π°Π³ΡΡΠΆΠ΅Π½Π½ΡΡ ΠΈΠ· ΡΠ΅ΠΏΠΎΠ·ΠΈΡΠΎΡΠΈΡ PRIDE
- 4. 4. 3. ΠΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ ΠΎΠ΄Π½ΠΎΠ°ΠΌΠΈΠ½ΠΎΠΊΠΈΡΠ»ΠΎΡΠ½ΡΡ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠΎΠ²
- 4. 5. ΠΠ½Π°Π»ΠΈΠ· ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΠΠ
- 4. 5. 1. ΠΠ½Π°Π»ΠΈΠ· ΠΠΠ-ΡΠΎΠ΄Π΅ΡΠΆΠ°ΡΠΈΡ ΠΏΠ΅ΠΏΡΠΈΠ΄ΠΎΠ²
- 4. 5. 2. Π‘Π²ΡΠ·Ρ Π²ΡΡΠ²Π»Π΅Π½Π½ΡΡ ΠΠΠ Ρ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΠΌΠΈ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- ΠΡΡΠ°ΠΊΠΎΠ² Π.Π. ΠΈ Π΄Ρ. Π‘ΠΏΠΎΡΠΎΠ± ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΡ ΡΠΎΡΠ½ΠΎΡΡΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ Π°ΠΌΠΈΠ½ΠΎΠΊΠΈΡΠ»ΠΎΡΠ½ΡΡ ΠΎΡΡΠ°ΡΠΊΠΎΠ² Π±ΠΈΠΎΠΏΠΎΠ»ΠΈΠΌΠ΅ΡΠ° Π½Π° ΠΎΡΠ½ΠΎΠ²Π΅ Π΄Π°Π½Π½ΡΡ ΠΌΠ°ΡΡΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π°, Π²ΡΡΠΈΡΠ»ΠΈΡΠ΅Π»ΡΠ½Π°Ρ ΡΠΈΡΡΠ΅ΠΌΠ° //2010.
- ΠΡΡΠ°ΠΊΠΎΠ² Π.Π. ΠΈ Π΄Ρ. Π¦ΠΈΡΠΎΡ ΡΠΎΠΌΡ Π 450, Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½Π°Ρ Π±ΠΎΠ»Π΅Π·Π½Ρ ΠΈ ΠΏΠ΅ΡΡΠΎΠ½ΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½Π°Ρ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½Π°. Π§Π°ΡΡΡ 1 // ΠΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½Π°. 2008. Π’. 86. № 2. Π‘. 4−8.
- ΠΠ»ΡΠ΅Π² H.A., ΠΡΠΎΠ΄ΡΠΊΠΈΠΉ Π. Π‘. Π‘ΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΠ΅ ΠΌΠ΅ΡΠΎΠ΄Ρ ΠΌΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° ΠΎΡΠ³Π°Π½ΠΈΡΠ΅ΡΠΊΠΈΡ ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΠΉ // Π ΠΎΡ. Ρ ΠΈΠΌ. ΠΆ. (Π. Π ΠΎΡ. Ρ ΠΈΠΌ. ΠΎΠ±-Π²Π° ΠΈΠΌ. Π.Π. ΠΠ΅Π½Π΄Π΅Π»Π΅Π΅Π²Π°). 2002. Π’. XLVI. № 4. Π‘. 57−63.
- ΠΠΈΡΠΈΡΠ° A.B. ΠΈ Π΄Ρ. ΠΠ΄Π½ΠΎΠΌΠ΅ΡΠ½ΠΎΠ΅ ΠΏΡΠΎΡΠ΅ΠΎΠΌΠ½ΠΎΠ΅ ΠΊΠ°ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠΈΡΠΎΡ ΡΠΎΠΌΠΎΠ² Π 450 ΠΏΠ΅ΡΠ΅Π½ΠΈ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ° // ΠΠΈΠΎΡ ΠΈΠΌΠΈΡ. 2009. Π’. 74. № 2. Π‘. 153−161.
- ΠΡΡΠΎΠ΅Π΄ΠΎΠ²Π° Π.Π. ΠΠΎΠ²ΠΎΠ΅ Π² ΠΈΠ·ΡΡΠ΅Π½ΠΈΠΈ ΡΠΈΡΠΎΡ ΡΠΎΠΌΠΎΠ² Π 450 // ΠΠΈΠΎΡ ΠΈΠΌΠΈΡ. 2008. Π’. 73. № 9. Π‘. 1199−1205.
- ΠΠ΅ΡΡΡΠΊΠΎΠ²Π° H.A. ΠΈ Π΄Ρ. ΠΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ ΡΠΈΡΠΎΡ ΡΠΎΠΌΠΎΠ² Π 450 ΠΌΠΈΠΊΡΠΎΡΠΎΠΌ ΠΊΠ»Π΅ΡΠΎΠΊ ΠΏΠ΅ΡΠ΅Π½ΠΈ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ° Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΌΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΠΈ // ΠΠΈΠΎΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠ°Ρ Ρ ΠΈΠΌΠΈΡ. 2007. Π’. 53. № 4. Π‘. 400−11.
- ΠΠΎΠ½ΠΎΠΌΠ°ΡΠ΅Π½ΠΊΠΎ Π.Π., ΠΠ»ΡΠ³ΠΈΡΠΎΠ½ΠΈΡ Π. Π., ΠΠΈΡΠΈΡΠ° A.B. Π’Π΅Ρ Π½ΠΎΠ»ΠΎΠ³ΠΈΠΈ Π·Π½Π°Π½ΠΈΠΉ Π² ΠΏΡΠΎΡΠ΅ΠΎΠΌΠΈΠΊΠ΅ // ΠΠΈΠΎΠΎΡΠ³Π°Π½ΠΈΡΠ΅ΡΠΊΠ°Ρ Ρ ΠΈΠΌΠΈΡ. 2011. Π’. 37. № 2. Π‘. 190−198.
- ΠΠΎΠ½ΠΎΠΌΠ°ΡΠ΅Π½ΠΊΠΎ Π.Π. ΠΈ Π΄Ρ. ΠΡΡΠ²Π»Π΅Π½ΠΈΠ΅ Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½ΠΎ-ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡΡΡΡΠΈΡ ΡΡ Π±Π΅Π»ΠΊΠΎΠ² Ρ ΠΈΡΠΏΠΎΠ»ΡΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ Π°Π²ΡΠΎΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΌΠ΅ΡΠ°-Π°Π½Π°Π»ΠΈΠ·Π° ΠΏΡΠΎΡΠ΅ΠΎΠΌΠ½ΡΡ ΠΏΡΠ±Π»ΠΈΠΊΠ°ΡΠΈΠΉ // ΠΠΈΠΎΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠ°Ρ Ρ ΠΈΠΌΠΈΡ. 2009. Π’. 3. № 1. Π‘. 10−16.
- Π‘Π°Π²Π΅Π»ΡΠ΅Π²Π° Π. ΠΈ Π΄Ρ. ΠΠ½Π°ΡΠ΅Π½ΠΈΠ΅ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠ° ΠΈΠ·ΠΎΡΠ΅ΡΠΌΠ΅Π½ΡΠΎΠ² ΡΠΈΡΠΎΡ ΡΠΎΠΌΠ° Π 450 Π΄Π»Ρ ΠΏΠ΅ΡΡΠΎΠ½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ Π²ΡΠ±ΠΎΡΠ° ΠΈ ΡΠ΅ΠΆΠΈΠΌΠΎΠ² Π΄ΠΎΠ·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π°Π½ΡΠΈΠ΄Π΅ΠΏΡΠ΅ΡΡΠ°Π½ΡΠΎΠ² ΠΈ Π°Π½ΡΠΈΠΏΡΠΈΡ ΠΎΡΠΈΠΊΠΎΠ² // ΠΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½Π°. 2008. Π’. 86. № 11. Π‘. 22−28.
- A gene-centric human proteome project: HUPO~the Human Proteome organization. // Molecular & cellular proteomics: MCP. 2010. Π’. 9. № 2. Π‘. 4279.
- Aebersold R., Mann M. Mass spectrometry-based proteomics. // Nature. 2003. T. 422. № 6928. C. 198−207.
- Ahrne E., Mtiller M., Lisacek F. Unrestricted identification of modified proteins using MS/MS // Proteomics. 2010. T. 10. № 4. C. 671−686.
- Akiyama M. h «p. Ichthyosis bullosa of Siemens: its correct diagnosis facilitated by molecular genetic testing. // The British journal of dermatology. 2005. T. 152. № 6. C. 1353−6.
- Alves G. h jxp. Calibrating E-values for MS2 database search methods. // Biology direct. 2007. T. 2. № 1. C. 26.
- Alves G., Ogurtsov A.Y., Yu Y.-K. RAId DbS: mass-spectrometry based peptide identification web server with knowledge integration. // BMC genomics. 2008. T. 9. C. 505.
- Archakov A. h zip. Biospecific irreversible fishing coupled with atomic force microscopy for detection of extremely low-abundant proteins. // Proteomics. 2009. T. 9. № 5. C. 1326−43.
- Archakov A. h ap. Gene-centric view on the human proteome project: the example of the Russian roadmap for chromosome 18. // Proteomics. 2011. T. 11. № 10. C. 1853−6.
- Archakov A.I. h zip. AFM fishing nanotechnology is the way to reverse the Avogadro number in proteomics. // Proteomics. 2007. T. 7. № 1. C. 4−9.
- Archakov A.I., Bachmanova G.I. Cytochrome P-450 and active oxygen. London: Taylor & Francis, 1990.
- Asara J.M. hp. A label-free quantification method by MS/MS TIC compared to SILAC and spectral counting in a proteomics screen. // Proteomics. 2008. T. 8. № 5. C. 994−9.
- Bairoch A., Apweiler R. The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000. // Nucleic acids research. 2000. T. 28. № 1. C. 45−8.
- Baldwin M. a. Protein identification by mass spectrometry: issues to be considered. //Molecular & cellular proteomics: MCP. 2004. T. 3. № 1. C. 1−9.
- Bantscheff M. h ap. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. // Nature biotechnology. 2007a. T. 25. № 9. C. 1035−44.
- Bantscheff M. h, qp. Quantitative mass spectrometry in proteomics: a critical review. //Analytical and bioanalytical chemistry. 2007b. T. 389. № 4. C. 1017−31.
- Barsnes H. h ap. PRIDE Converter: making proteomics data-sharing easy. // Nature biotechnology. 2009. T. 27. № 7. C. 598−9.
- Baumgardner L.A. h Fast parallel tandem mass spectral library searching using GPU hardware acceleration. // Journal of proteome research. 2011. T. 10. № 6. C. 2882−8.
- Beck F. h ap. The good, the bad, the ugly: Validating the mass spectrometric analysis of modified peptides // PROTEOMICS. 2011. C. n/a-n/a.
- Bell A.W. h /jp. The protein microscope: incorporating mass spectrometry into cell biology. //Nature methods. 2007. T. 4. № 10. C. 783−4.
- Binz P.-A. h, qp. A Molecular Scanner To Automate Proteomic Research and To Display Proteome Images // Analytical Chemistry. 1999. T. 71. № 21. C. 49 814 988.
- Binz P.-A. h pp. The molecular scanner: concept and developments. // Current opinion in biotechnology. 2004. T. 15. № 1. C. 17−23.
- Birney E. h ap. An overview of Ensembl. // Genome research. 2004. T. 14. № 5. C. 925−8.
- Birney E., Clamp M., Hubbard T. Databases and tools for browsing genomes. // Annual review of genomics and human genetics. 2002. T. 3. C. 293−310.
- Bochet P. h flp. Fragmentation-free LC-MS can identify hundreds of proteins // PROTEOMICS. 2010. T. 11. № 1. C. n/a-n/a.
- Boguski M.S., Lowe T.M., Tolstoshev C.M. dbEST-database for «expressed sequence tags». // Nature genetics. 1993. T. 4. № 4. C. 332−3.
- Borges C.R. h np. Full-length characterization of proteins in human populations. // Clinical chemistry. 2010. T. 56. № 2. C. 202−11.
- Bromberg Y., Rost B. SNAP: predict effect of non-synonymous polymorphisms on function. //Nucleic acids research. 2007. T. 35. № 11. C. 3823−35.
- Brosch M. h np. Comparison of Mascot and XITandem performance for low and high accuracy mass spectrometry and the development of an adjusted Mascot threshold. // Molecular & cellular proteomics: MCP. 2008. T. 7. № 5. C. 962−70.
- Bunger M.K. hp. Detection and validation of non-synonymous coding SNPs from orthogonal analysis of shotgun proteomics data. // Journal of proteome research. 2007. T. 6. № 6. C. 2331−40.
- Bunkenborg J. h jip. Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. // Proteomics. 2004. T. 4. № 2. C. 454−65.
- Butenas S., Mann K.G., Butenas B. Blood Coagulation.: MAIK Nauka/Interperiodica distributed exclusively by Springer Science+Business Media LLC., 2002.
- Canas B. h jyp. Mass spectrometry technologies for proteomics. // Briefings in functional genomics & proteomics. 2006. T. 4. № 4. C. 295−320.
- Care M.A. h Deleterious SNP prediction: be mindful of your training data! // Bioinformatics (Oxford, England). 2007. T. 23. № 6. C. 664−72.
- Casado-Vela J. h flp. Lights and shadows of proteomic technologies for the study of protein species including isoforms, splicing variants and protein post-translational modifications. // Proteomics. 2011. T. 11. № 4. C. 590−603.
- Chapman P.F. h ap. Genes, models and Alzheimer’s disease // Trends in Genetics. 2001. T. 17. № 5. C. 254−261.
- Chen M. h ap. Annotation of Non-Synonymous Single Polymorphisms in Human Liver Proteome by Mass Spectrometry // Protein and Peptide Letters. 2010. T. 17. № 3. C. 277−286.
- Chen R. h zip. Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. // Journal of proteome research. 2009. T. 8. № 2. C. 651−61.
- Choudhary J.S. h Interrogating the human genome using uninterpreted mass spectrometry data. // Proteomics. 2001a. T. 1. № 5. C. 651−67.
- Choudhary J.S. h «p. Matching peptide mass spectra to EST and genomic DNA databases. // Trends in biotechnology. 2001b. T. 19. № 10 Suppl. C. S17−22.
- Choudhury V. h ap. Two novel antithrombin variants (L99V and Q118P) which alter the heparin binding // Nouvelle Revue Francaise. 1994. T. 36. C. 268.
- Colinge J., Bennett K.L. Introduction to computational proteomics. // PLoS computational biology. 2007. T. 3. № 7. C. el 14.
- Cooksey A.M. h ap. Identifying blood biomarkers and physiological processes that distinguish humans with superior performance under psychological stress. // PloS one. 2009. T. 4. № 12. C. e8371.
- Cooper D. The human gene mutation database // Nucleic Acids Research. 1998. T. 26. β l.C. 285−287.
- Cote R.G. h up. The Ontology Lookup Service: more data and better tools for controlled vocabulary queries. // Nucleic acids research. 2008. T. 36. β Web Server issue. C. W372−6.
- Cottrell J.S. Protein identification by peptide mass fingerprinting. // Peptide research. 1994. T. 7. № 3. C. 115−24.
- Craig R., Beavis R.C. TANDEM: matching proteins with tandem mass spectra. // Bioinformatics (Oxford, England). 2004. T. 20. № 9. C. 1466−7.
- Craig R., Cortens J.P., Beavis R.C. Open source system for analyzing, validating, and storing protein identification data. // Journal of proteome research. 2004. T. 3. № 6. C. 1234−42.
- Creasy D.M., Cottrell J.S. Error tolerant searching of uninterpreted tandem mass spectrometry data // PROTEOMICS. 2002. T. 2. № 10. C. 1426−1434.
- Crockett D.K. h ap. Annotated proteome of a human T-cell lymphoma. // Journal of biomolecular techniques: JBT. 2005. T. 16. № 4. C. 341−6.
- Dai D. h jvp. Identification of Variants of CYP3A4 and Characterization of Their Abilities to Metabolize Testosterone and Chlorpyrifos // J. Pharmacol. Exp. Ther. 2001. T. 299. № 3. C. 825−831.
- Delahunty C., Yates J.R. Identification of proteins in complex mixtures using liquid chromatography and mass spectrometry. // Current protocols in cell biology / editorial board, Juan S. Bonifacino. et al. 2003. T. Chapter 5. C. Unit 5.6.
- Delahunty C.M., Iii J.R.Y. Tech Insight MudPIT: multidimensional protein identification technology Tech Insight // Biotechniques. 2007. T. 43. № 5.
- Desiere F. h jjp. The PeptideAtlas project. // Nucleic acids research. 2006. T. 34. β Database issue. C. D655−8.
- Deutsch E. mzML: a single, unifying data format for mass spectrometer output. // Proteomics. 2008. T. 8. № 14. C. 2776−7.
- Deutsch E.W. The PeptideAtlas Project. // Methods in molecular biology (Clifton, N.J.). 2010. T. 604. C. 285−96.
- Deutsch E.W. hp. A guided tour of the Trans-Proteomic Pipeline. // Proteomics. 2010. T. 10. № 6. C. 1150−9.
- Deutsch E.W. hp. Human Plasma PeptideAtlas. // Proteomics. 2005. T. 5. № 13. C. 3497−500.
- Deutsch E.W., Lam H., Aebersold R. PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows. // EMBO reports. 2008. T. 9. № 5. C. 429−34.
- Eckel-Passow J.E. h jsp. An insight into high-resolution mass-spectrometry data. // Biostatistics (Oxford, England). 2009. T. 10. № 3. C. 481−500.
- Eng J.K., McCormack A.L., Yates III J.R. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database // Journal of the American Society for Mass Spectrometry. 1994. T. 5. № 11. C. 976−989.
- Eriksson J., Fenyo D. Probity: A Protein Identification Algorithm with Accurate Assignment of the Statistical Significance of the Results // Journal of Proteome Research. 2004. T. 3. № 1. C. 32−36.
- Falkner J. a h up. Validated MALDI-TOF/TOF mass spectra for protein standards. // Journal of the American Society for Mass Spectrometry. 2007. T. 18. № 5. C. 850−5.
- Farrah T. h A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. // Molecular & cellular proteomics: MCP. 2011.
- Field D., Wilson G., Gast C. van der. How do we compare hundreds of bacterial genomes? // Current opinion in microbiology. 2006. T. 9. № 5. C. 499−504.
- Frazer K. a h ap. A second generation human haplotype map of over 3.1 million SNPs. //Nature. 2007. T. 449. № 7164. C. 851−61.
- Fredman D. h ap. HGVbase: a curated resource describing human DNA variation and phenotype relationships. // Nucleic acids research. 2004. T. 32. β Database issue. C. D516−9.
- Freed G.L. hp. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples. // The Laryngoscope. 2008. T. 118. № 1. C. 61−8.
- Gabellini N. NTRK2 (Neurotrophic tyrosine kinase, receptor, type 2) // Atlas Genet Cytogenet Oncol Haematol. 2008. T. 12. № 4. C. 314−317.
- Galeva N. Direct Identification of Cytochrome P450 Isozymes by Matrix-assisted Laser Desorption/Ionization Time of Flight-Based Proteomic Approach // Drug Metabolism and Disposition. 2003. T. 31. № 4. C. 351−355.
- Galeva N., Altermann M. Comparison of one-dimensional and two-dimensional gel electrophoresis as a separation tool for proteomic analysis of rat liver microsomes: cytochromes P450 and other membrane proteins. // Proteomics. 2002. T. 2. № 6. C. 713−22.
- Gao M. h jp. Large scale depletion of the high-abundance proteins and analysis of middle- and low-abundance proteins in human liver proteome bymultidimensional liquid chromatography. // Proteomics. 2008. T. 8. № 5. C. 93 947.
- Garcia-Blanco M. a, Baraniak A.P., Lasda E.L. Alternative splicing in disease and therapy. // Nature biotechnology. 2004. T. 22. № 5. C. 535−46.
- Gatlin C.L. h ap. Automated Identification of Amino Acid Sequence Variations in Proteins by HPLC/Microspray Tandem Mass Spectrometry // Analytical Chemistry. 2000. T. 72. № 4. C. 757−763.
- Gobom J. h? p. A Calibration Method That Simplifies and Improves Accurate Determination of Peptide Molecular Masses by MALDI-TOF MS // Analytical Chemistry. 2002. T. 74. № 15. C. 3915−3923.
- Griss J. h ap. Published and Perished? the influence of the searched protein database on the long-term storage of proteomics data. // Molecular & cellular proteomics: MCP. 2011. T. 10. № 9. C. Ml 11.8 490.
- Grone J. hp. Differential expression of genes encoding tight junction proteins in colorectal cancer: frequent dysregulation of claudin-1, -8 and -12. // International journal of colorectal disease. 2007. T. 22. № 6. C. 651−9.
- Hamosh A. h? p. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. // Nucleic acids research. 2005. T. 33. β Database issue. C. D514−7.
- Hamosh A. h ap. Online Mendelian Inheritance in Man (OMIM). // Human mutation. 2000. T. 15. № 1. C. 57−61.
- Han X., Aslanian A., Yates III J.R. Mass spectrometry for proteomics // Current Opinion in Chemical Biology. 2008. T. 12. № 5. C. 483−490.
- Hedden P. h ap. Gibberellin Biosynthesis in Plants and Fungi: A Case of Convergent Evolution? // Journal of plant growth regulation. 2001. T. 20. № 4. C. 319−331.
- Hopfgartner G. h Triple quadrupole linear ion trap mass spectrometer for the analysis of small molecules and macromolecules. // Journal of mass spectrometry: JMS. 2004. T. 39. № 8. C. 845−55.
- Huang Y. n flp. Statistical characterization of the charge state and residue dependence of low-energy CID peptide dissociation patterns. // Analytical chemistry. 2005. T. 77. № 18. C. 5800−13.
- Hubbard T. The Ensembl genome database project // Nucleic Acids Research. 2002. T. 30. № 1. C. 38−41.
- Hustert E. h? p. The genetic determinants of the CYP3A5 polymorphism. // Pharmacogenetics. 2001. T. 11. № 9. c. 773−9.
- Ilina E.N. hp. Direct bacterial profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for identification of pathogenic Neisseria. // The Journal of molecular diagnostics: JMD. 2009. T. 11. № 1. C. 7586.
- Ingelman-Sundberg M. Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms. // Naunyn-Schmiedeberg's archives of pharmacology. 2004. T. 369. № 1. C. 89−104.
- International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. // Nature. 2004. T. 431. № 7011. C. 931 -45.
- Ishihama Y. h pp. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. // Molecular & cellular proteomics: MCP. 2005. T. 4. № 9. C. 1265−72.
- Jain R., Wagner M. Kolmogorov-Smirnov scores and intrinsic mass tolerances for peptide mass fingerprinting. // Journal of proteome research. 2010. T. 9. № 2. C. 737−42.
- Jeffrey L. Cummings. Genotype-proteotype-phenotype relationships in neurodegenerative diseases.: Springer, 2005.
- Jenkins R.E. h ap. Relative and absolute quantitative expression profiling of cytochromes P450 using isotope-coded affinity tags. // Proteomics. 2006. T. 6. № 6. C. 1934−47.
- Jones P. h flp. PRIDE: a public repositoiy of protein and peptide identifications for the proteomics community. // Nucleic acids research. 2006. T. 34. β Database issue. C. D659−63.
- Jones P. h flp. PRIDE: new developments and new datasets. // Nucleic acids research. 2008. T. 36. β Database issue. C. D878−83.
- Kalmar L. h jip. Mutation screening of the CI inhibitor gene among Hungarian patients with hereditary angioedema. // Human mutation. 2003. T. 22. № 6. C. 498.
- Keller A. h ap. Empirical Statistical Model To Estimate the Accuracy of Peptide Identifications Made by MS/MS and Database Search // Analytical Chemistry. 2002. T. 74. № 20. C. 5383−5392.
- Kersey P.J. n jjp. The International Protein Index: an integrated database for proteomics experiments. // Proteomics. 2004. T. 4. № 7. C. 1985−8.
- Kim S., Gupta N., Pevzner P. a. Spectral probabilities and generating functions of tandem mass spectra: a strike against decoy databases. // Journal of proteome research. 2008. T. 7. № 8. C. 3354−63.
- Klie S. h? p. Analyzing large-scale proteomics projects with latent semantic indexing. // Journal of proteome research. 2008. T. 7. № 1. C. 182−91.
- Kremer H. h up. Ichthyosis Bullosa of Siemens Is Caused by Mutations in the Keratin 2e Gene. // Journal of Investigative Dermatology. 1994. T. 103. № 3. C. 286−289.
- Kuehl P. h ap. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. // Nature genetics. 2001. T. 27. № 4. C. 383−91.
- Kuhn R.M. h up. The UCSC Genome Browser Database: update 2009. // Nucleic acids research. 2009. T. 37. β Database issue. C. D755−61.
- Kuster B. h flp. Mass spectrometry allows direct identification of proteins in large genomes. //Proteomics. 2001. T. 1. № 5. c. 641−50.
- Lane C.S. h ap. Comparative cytochrome P450 proteomics in the livers of immunodeficient mice using 180 stable isotope labeling. // Molecular & cellular proteomics: MCP. 2007. T. 6. № 6. C. 953−62.
- Lane C.S. h, qp. Identification of cytochrome P450 enzymes in human colorectal metastases and the surrounding liver: a proteomic approach. // European journal of cancer (Oxford, England: 1990). 2004. T. 40. № 14. C. 2127−34.
- Lane E.B., McLean W.H.I. Keratins and skin disorders. // The Journal of pathology. 2004. T. 204. № 4. C. 355−66.
- Levine a J. P53, the Cellular Gatekeeper for Growth and Division. // Cell. 1997. T. 88. № 3. C. 323−31.
- Levy S. h AP- The diploid genome sequence of an individual human. // PLoS biology. 2007. T. 5. № 10. C. e254.
- Lewis D.F.V. 57 varieties: the human cytochromes P450. // Pharmacogenomics. 2004. T. 5. № 3. C. 305−18.
- Lim A. h ap. Characterization of Transthyretin Variants in Familial Transthyretin Amyloidosis by Mass Spectrometric Peptide Mapping and DNA Sequence Analysis // Analytical Chemistry. 2002. T. 74. № 4. C. 741−751.
- Lim H. Identification of 2D-gel proteins: A comparison of MALDI/TOF peptide mass mapping to p LC-ESI tandem mass spectrometry // Journal of the American Society for Mass Spectrometry. 2003. T. 14. № 9. C. 957−970.
- Lisitsa A.V. h «p. Application of slicing of one-dimensional gels with subsequent slice-by-slice mass spectrometry for the proteomic profiling of human liver cytochromes P450. // Journal ofproteome research. 2010. T. 9. № 1. C. 95−103.
- Liu T. h ap. High dynamic range characterization of the trauma patient plasma proteome. // Molecular & cellular proteomics: MCP. 2006. T. 5. № 10. C. 1 899 913.
- Liu T. h /ip. Human Plasma N-Glycoproteome Analysis by Immunoaffinity Subtraction, Hydrazide Chemistry, and Mass Spectrometry // Journal of proteome research. 2005. T. 4. № 6. C. 2070−2080.
- Mallick P. h flp. Computational prediction of proteotypic peptides for quantitative proteomics. //Nature biotechnology. 2007. T. 25. № 1. C. 125−31.
- Mann M., Jensen O.N. Proteomic analysis of post-translational modifications. // Nature biotechnology. 2003. T. 21. № 3. C. 255−61.
- Mann M., Wilm M. Error-Tolerant Identification of Peptides in Sequence Databases by Peptide Sequence Tags // Analytical Chemistry. 1994. T. 66. № 24. C. 4390−4399.
- Marchetti A. h pp. Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung. // Human mutation. 2008. T. 29. № 5. C. 609−16.
- Marichal P. h Contribution of mutations in the cytochrome P450 14{alpha}-demethylase (Ergllp, Cyp51p) to azole resistance in Candida albicans // Microbiology. 1999. T. 145. № 10. C. 2701−2713.
- Martens L. h jxp. PRIDE: the proteomics identifications database. // Proteomics. 2005. T. 5. № 13. C. 3537−45.
- Matthiesen R., Amorim A. Proteomics facing the combinatorial problem. // Methods in molecular biology (Clifton, N.J.). 2010. T. 593. C. 175−86.
- McDonald W.H., Yates J.R. Shotgun proteomics: integrating technologies to answer biological questions. // Current opinion in molecular therapeutics. 2003. T. 5. № 3. C. 302−9.
- Menon R., Omenn G.S. Proteomic characterization of novel alternative splice variant proteins in human epidermal growth factor receptor 2/neu-induced breast cancers. // Cancer research. 2010. T. 70. № 9. C. 3440−9.
- Menschaert G. h? p. Peptidomics coming of age: a review of contributions from a bioinformatics angle. // Journal of proteome research. 2010. T. 9. № 5. C. 205 161.
- Millar D.S. h Three novel missense mutations in the antithrombin III (AT3) gene causing recurrent venous thrombosis. // Human genetics. 1994. T. 94. № 5. C. 509−12.
- Mironov A.A. Frequent Alternative Splicing of Human Genes // Genome Research. 1999. T. 9. № 12. C. 1288−1293.
- Modrek B. Genome-wide detection of alternative splicing in expressed sequences of human genes //Nucleic Acids Research. 2001. T. 29. № 13. C. 2850−2859.
- Mueller M. h ap. Analysis of the experimental detection of central nervous system-related genes in human brain and cerebrospinal fluid datasets. // Proteomics. 2008. T. 8. № 6. C. 1138−48.
- Nagaraj S.H., Gasser R.B., Ranganathan S. A hitchhiker’s guide to expressed sequence tag (EST) analysis. // Briefings in bioinformatics. 2007. T. 8. № 1. C. 621.
- Nedelkov D. Population proteomics: Investigation of protein diversity in human populations // Proteomics. 2008. T. 8. № 4. C. 779−86.
- Nedelkov D. h ap. High-throughput comprehensive analysis of human plasma proteins: a step toward population proteomics. // Analytical chemistry. 2004. T. 76. № 6. C. 1733−7.
- Nedelkov D. hp. Investigating diversity in human plasma proteins. // Proceedings of the National Academy of Sciences of the United States of America. 2005. T. 102. № 31. C. 10 852−7.
- Nesvizhskii A.I. Protein identification by tandem mass spectrometry and sequence database searching. // Methods in molecular biology (Clifton, N.J.). 2007. T. 367. C. 87−119.
- Nesvizhskii A.I., Vitek O., Aebersold R. Analysis and validation of proteomic data generated by tandem mass spectrometry // Nature Methods. 2007. T. 4. № 10. C. 787−797.
- Ng P.C. h flp. Genetic Variation in an individual human exome // PLoS Genetics. 2008. T. 4. № 8.
- Ong S.-E., Mann M. Mass spectrometry-based proteomics turns quantitative. // Nature chemical biology. 2005. T. 1. № 5. c. 252−62.
- Ossipova E., Fenyo D., Eriksson J. Optimizing search conditions for the mass fingerprint-based identification of proteins. // Proteomics. 2006. T. 6. № 7. C. 2079−85.
- Overbeek R. h, np. Annotation of bacterial and archaeal genomes: improving accuracy and consistency. // Chemical reviews. 2007. T. 107. № 8. C. 3431−47.
- Pedrioli P.G.A. Trans-proteomic pipeline: a pipeline for proteomic analysis. // Methods in molecular biology (Clifton, N.J.). 2010. T. 604. C. 213−38.
- Perkins D.N. hp. Probability-based protein identification by searching sequence databases using mass spectrometry data // Electrophoresis. 1999. T. 20. № 18. C. 3551−3567.
- Perry D.J., Carrell R.W. Molecular genetics of human antithrombin deficiency. // Human mutation. 1996. T. 7. № 1. C. 7−22.
- Petrak J. h ap. Deja vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins. // Proteomics. 2008. T. 8. № 9. C. 1744−9.
- Pevzner P.A. h /ip. Efficiency of database search for identification of mutated and modified proteins via mass spectrometry. // Genome research. 2001. T. 11. № 2. C. 290−9.
- Porter C.J., Talbot C.C., Cuticchia A.J. Central mutation databases-a review. // Human mutation. 2000. T. 15. № 1. C. 36−44.
- Rabilloud T., Hochstrasser D., Simpson R.J. Is a gene-centric human proteome project the best way for proteomics to serve biology? // Proteomics. 2010. C. 1−6.
- Rappsilber J. h? p. Large-scale proteomic analysis of the human spliceosome. // Genome research. 2002. T. 12. № 8. C. 1231−45.
- Redlich G. h zip. Distinction between human cytochrome P450 (CYP) isoforms and identification of new phosphorylation sites by mass spectrometry. // Journal of proteome research. 2008. T. 7. № 11. C. 4678−88.
- Reid G.E., McLuckey S.A. «Top down» protein characterization via tandem mass spectrometiy. // Journal of mass spectrometry: JMS. 2002. T. 37. № 7. C. 663−75.
- Rodriguez C. h zip. Proteotyping of human haptoglobin by MALDI-TOF profiling: Phenotype distribution in a population of toxic oil syndrome patients. // Proteomics. 2006. T. 6. C. S272--81.
- Roher A. h zip. Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer’s disease // J. Biol. Chem. 1993. T. 268. № 5. c. 3072−3083.
- Rostami-Hodjegan A., Tucker G.T. Simulation and prediction of in vivo drug metabolism in human populations from in vitro data. // Nature reviews. Drug discovery. 2007. T. 6. № 2. C. 140−8.
- Roth M.J. h zip. «Proteotyping»: population proteomics of human leukocytes using top down mass spectrometry. // Analytical chemistry. 2008. T. 80. № 8. C. 285 766.
- Rozman D., Waterman M.R. Lanosterol 14alpha -Demethylase (CYP51) and Spermatogenesis // Drug Metab. Dispos. 1998. T. 26. № 12. C. 1199−1201.
- Rubina A.Y. h zip. Why 3-D? Gel-based microarrays in proteomics. // Proteomics. 2008. T. 8. № 4. C. 817−31.
- Sadygov R.G., Cociorva D., Iii J.R.Y. Large-scale database searching using tandem mass spectra: Looking up the answer in the back of the book // Nature Methods. 2004. T. 1. № 3. C. 195−202.
- Sarkozy A. h zip. Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum. // Human mutation. 2009. T. 30. № 4. C. 695−702.
- Sattelle D.B., Jones A.K., Buckingham S.D. Insect genomes: challenges and opportunities for neuroscience. // Invertebrate neuroscience: IN. 2007. T. 7. № 3. C. 133−6.
- Schandorff S. h, np. A mass spectrometry-friendly database for cSNP identification. //Nature methods. 2007. T. 4. № 6. C. 465−6.
- Schmuth M. h Ichthyosis update: towards a function-driven model of pathogenesis of the disorders of cornification and the role of corneocyte proteins in these disorders. //Advances in dermatology. 2007. T. 23. C. 231−56.
- Schweigert F.J., Wirth K., Raila J. Characterization of the microheterogeneity of transthyretin in plasma and urine using SELDI-TOF-MS immunoassay. // Proteome science. 2004. T. 2. № 1. C. 5.
- Searle B.C., Turner M., Nesvizhskii A.I. Improving sensitivity by probabilistically combining results from multiple MS/MS search methodologies. // Journal of proteome research. 2008. T. 7. № 1. C. 245−53.
- Seo J., Lee K.-J. Post-translational modifications and their biological functions: proteomic analysis and systematic approaches. // Journal of biochemistry and molecular biology. 2004. T. 37. № 1. C. 35−44.
- Sherry S.T. dbSNP: the NCBI database of genetic variation // Nucleic Acids Research. 2001. T. 29. № 1. C. 308−311.
- Shevchenko A. h jp. Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels // Analytical Chemistry. 1996. T. 68. № 5. C. 850 858.
- Shi W.-feng h up. Proteotyping: A new approach studying influenza virus evolution at the protein level // Virologica Sinica. 2008. T. 22. № 5. C. 405−411.
- Shteynberg D. h np. iProphet: Multi-level integrative analysis of shotgun proteomic data improves peptide and protein identification rates and error estimates. // Molecular & cellular proteomics: MCP. 2011. C. Ml 11.7 690-.
- Smigielski E.M. dbSNP: a database of single nucleotide polymorphisms // Nucleic Acids Research. 2000. T. 28. № 1. C. 352−355.
- Srebrow A., Kornblihtt A.R. The connection between splicing and cancer. // Journal of cell science. 2006. T. 119. β Pt 13. C. 2635−41.
- Stamm S. h zip. ASD: a bioinformatics resource on alternative splicing. // Nucleic acids research. 2006. T. 34. β Database issue. C. D46−55.
- Stein P.E., Carrell R.W. What do dysfunctional serpins tell us about molecular mobility and disease? // Nature Structural Biology. 1995. T. 2. № 2. C. 96−113.
- Supek F. n zip. Enhanced analytical power of SDS-PAGE using machine learning algorithms. //Proteomics. 2008. T. 8. № 1. C. 28−31.
- Taylor C.F. Minimum reporting requirements for proteomics: a MIAPE primer. // Proteomics. 2006. T. 6 Suppl 2. C. 39−44.
- Taylor C.F. h zip. The minimum information about a proteomics experiment (MIAPE). // Nature biotechnology. 2007. T. 25. № 8. C. 887−93.
- Thiede B. h zip. Peptide mass fingerprinting. // Methods (San Diego, Calif.). 2005. T. 35. № 3. C. 237−47.
- Tsvetkov P.O. h zip. Isomerization of the Asp7 residue results in zinc-induced oligomerization of Alzheimer’s disease amyloid beta (l-16) peptide. // Chembiochem: a European journal of chemical biology. 2008. T. 9. № 10. C. 1564−7.
- Uhlen M. h zip. A human protein atlas for normal and cancer tissues based on antibody proteomics. // Molecular & cellular proteomics: MCP. 2005. T. 4. № 12. C. 1920−32.
- Ullrich A. h zip. CANCER-RELATED PROTEIN KINASES // US Patent App. 12/. 2007.
- Venter J.C. h zip. The sequence of the human genome. // Science (New York, N.Y.). 2001. T. 291. № 5507. C. 1304−51.
- Vizcaino J.A., Foster J.M., Martens L. Proteomics data repositories: Providing a safe haven for your data and acting as a springboard for further research // Journal of Proteomics. 2010. C. 1−11.
- W Vogel K. h zip. Developing assays for kinase drug discovery where have the advances come from? // 2007.
- Westlind-Johnsson A. Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism // Drug Metabolism and Disposition. 2003. T. 31. β >6. C. 755−761.
- Wheeler D.L. h zip. Database resources of the National Center for Biotechnology Information. //Nucleic acids research. 2007. T. 35. β Database issue. C. D5−12.
- Whibley C., Pharoah P.D.P., Hollstein M. p53 polymorphisms: cancer implications. //Nature reviews. Cancer. 2009. T. 9. № 2. C. 95−107.
- Wilkins M.R. h /ip. From Proteins to Proteomes: Large Scale Protein Identification by Two-Dimensional Electrophoresis and Amino Acid Analysis // Bio/Technology. 1996. T. 14. № 1. C. 61−65.
- Wu C.H. h ap. The Universal Protein Resource (UniProt): an expanding universe of protein information. // Nucleic acids research. 2006. T. 34. β Database issue. C. D187−91.
- Yates J R., Eng J.K., McCormack A.L. Mining Genomes: Correlating Tandem Mass Spectra of Modified and Unmodified Peptides to Sequences in Nucleotide Databases // Analytical Chemistry. 1995. T. 67. № 18. C. 3202−3210.
- Yip Y.L. h Annotating single amino acid polymorphisms in the UniProt/Swiss-Prot knowledgebase. // Human mutation. 2008. T. 29. № 3. C. 3616.
- Zanger U.M. h ap. Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance. //Pharmacogenomics. 2007. T. 8. № 7. C. 743−59.
- Zgoda V.G. h? p. Proteomics of mouse liver microsomes: performance of different protein separation workflows for LC-MS/MS. // Proteomics. 2009. T. 9. № 16. C. 4102−5.
- Zhou H. h ap. Quantitative proteome analysis by solid-phase isotope tagging and mass spectrometry. //Nature biotechnology. 2002. T. 20. № 5. C. 512−5.
- Zubarev R.A., Zubarev A.R., Savitski M.M. Electron capture/transfer versus collisionally activated/induced dissociations: solo or duet? // Journal of the American Society for Mass Spectrometry. 2008. T. 19. № 6. C. 753−61.